Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units

키워드

참고문헌 (74)

1. Fridkin SK, "Magnitude and prevention of nosocomial infections in the intensive care unit", Infect Dis Clin North Am, 11, pp.479~496 (1997)
2. Vincent JL, "International study of the prevalence and outcomes of infection in intensive care units", JAMA, 302, pp.2323~2329 (2009)
3. Hidron AI, "NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007", Infect Control Hosp Epidemiol, 29, pp.996~1011 (2008)
4. Centers for Disease Control and Prevention, "Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities", MMWR Morb Mortal Wkly Rep, 58, pp.256~260 (2009)
5. Doi Y, "Treatment options for carbapenem-resistant gram-negative bacterial infections", Clin Infect Dis, 69(Suppl 7), pp.S565~S575 (2019)
6. (2019)[URL]
7. Adeolu M, "Genome-based phylogeny and taxonomy of the ‘Enterobacteriales’: proposal for Enterobacterales ord. nov. divided into the families Enterobacteriaceae, Erwiniaceae fam. nov., Pectobacteriaceae fam. nov., Yersiniaceae fam. nov., Hafniaceae fam. nov., Morganellaceae fam. nov., and Budviciaceae fam. nov", Int J Syst Evol Microbiol, 66, pp.5575~5599 (2016)
8. Logan LK, "The epidemiology of carbapenemresistant Enterobacteriaceae: the impact and evolution of a global menace", J Infect Dis, 215(suppl_1), pp.S28~S36 (2017)
9. Woodworth KR, "Vital signs: containment of novel multidrug-resistant organisms and resistance mechanisms. United States, 2006-2017", MMWR Morb Mortal Wkly Rep, 67, pp.396~401 (2018)
10. van Duin D, "The global epidemiology of carbapenemase-producing Enterobacteriaceae", Virulence, 8, pp.460~469 (2017)
11. Queenan AM, "Carbapenemases : the versatile betalactamases", Clin Microbiol Rev, 20, pp.440~458 (2007)
12. Viau R, "Intestinal carriage of carbapenemase-producing organisms : current status of surveillance methods", Clin Microbiol Rev, 29, pp.1~27 (2016)
13. Bush K, "The ABCD’s of β-lactamase nomenclature", J Infect Chemother, 19, pp.549~559 (2013)
14. Navon-Venezia S, "Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel", Antimicrob Agents Chemother, 50, pp.3098~3101 (2006)
15. Bratu S, "Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York", Clin Infect Dis, 44, pp.972~975 (2007)
16. Hossain A, "Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp", Antimicrob Agents Chemother, 48, pp.4438~4440 (2004)
17. Marchaim D, "Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes", Antimicrob Agents Chemother, 52, pp.1413~1418 (2008)
18. Walther-Rasmussen J, "OXA-type carbapenemases", J Antimicrob Chemother, 57, pp.373~383 (2006)
19. Yoon EJ, "A novel KPC variant KPC-55 in Klebsiella pneumoniae ST307 of reinforced meropenem-hydrolyzing activity", Front Microbiol, 11, pp.561317~ (2020)
20. Naas T, "Beta-lactamase database(BLDB) : structure and function", J Enzyme Inhib Med Chem, 32, pp.917~919 (2017)
21. (2021)[URL]
22. Guh AY, "Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012-2013", JAMA, 314, pp.1479~1487 (2015)
23. (2019)[URL]
24. Yigit H, "Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae", Antimicrob Agents Chemother, 45, pp.1151~1161 (2001)
25. Munoz-Price LS, "Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases", Lancet Infect Dis, 13, pp.785~796 (2013)
26. Zhang Y, "Epidemiology of carbapenem-resistant enterobacteriaceae infections:report from the China CRE Network", Antimicrob Agents Chemother, 62, pp.e01882~e01817 (2018)
27. Huang XL, "Active screening of intestinal carbapenem-resistant Enterobacteriaceae in high-risk patients admitted to the hematology wards and its effect evaluation", Zhonghua Xue Ye Xue Za Zhi, 41, pp.932~936 (2020)
28. Yan L, "Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital", Antimicrob Resist Infect Control, 9, pp.155~ (2020)
29. Zhang R, "Nationwide surveillance of clinical carbapenem-resistant Enterobacteriaceae(CRE)strains in China", EBioMedicine, 19, pp.98~106 (2017)
30. Watanabe M, "Transferable imipenem resistance in Pseudomonas aeruginosa", Antimicrob Agents Chemother, 35, pp.147~151 (1991)
31. Ohno Y, "Molecular epidemiology of carbapenemase-producing Enterobacteriaceae in a primary care hospital in Japan, 2010-2013", J Infect Chemother, 23, pp.224~229 (2017)
32. Yamamoto N, "Prevalence of, and risk factors for, carriage of carbapenem-resistant Enterobacteriaceae among hospitalized patients in Japan", J Hosp Infect, 97, pp.212~217 (2017)
33. Yong D, "Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India", Antimicrob Agents Chemother, 53, pp.5046~5054 (2009)
34. Park JW, "Status of carbapenemase-producing Enterobacteriaceae incidences in Korea, 2015–2016", Public Health Wkly Rep, 10, pp.1243~1247 (2017)
35. (2021)[URL]
36. (2021)[URL]
37. Sang-Hun Park, "Prevalence of Carbapenem-Resistant Enterobacteriaceae in Seoul, Korea", Journal of Bacteriology and Virology, 50(2), pp.107~116 (2020), 대한미생물학회
38. Kim MN, "Nosocomial clustering of NDM-1-producing Klebsiella pneumoniae sequence type 340 strains in four patients at a South Korean tertiary care hospital", J Clin Microbiol, 50, pp.1433~1436 (2012)
39. Yoon EJ, "New Delhi metallo-beta-lactamase-producing Enterobacteriaceae in South Korea between 2010 and 2015", Front Microbiol, 9, pp.571~ (2018)
40. Bo Min Kim, "Four Year Trend of Carbapenem-Resistance in Newly Opened ICUs of a University-Affiliated Hospital of South Korea", Tuberculosis and Respiratory Diseases, 72(4), pp.360~366 (2012), 대한결핵및호흡기학회[DOI]
41. 강진숙, "Prevalence and Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition in an Emergency Intensive Care Unit in a Tertiary Hospital in Korea: a Case-Control Study", Journal of Korean Medical Science, 34(18), pp.1~11 (2019), 대한의학회
42. Seo Hyeonji, "Risk Factors for Mortality in Patients with Klebsiella pneumoniae Carbapenemase-producing K. pneumoniae and Escherichia coli bacteremia", Infection and Chemotherapy, 53(3), pp.528~538 (2021), 대한감염학회[DOI]
43. 이효진, "Carbapenem-resistant Enterobacteriaceae: Prevalence and Risk Factors in a Single Community-Based Hospital in Korea", Infection and Chemotherapy, 48(3), pp.166~173 (2016), 대한감염학회
44. Papadimitriou-Olivgeris M, "KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay : the significance of risk factors for its development and its impact on mortality", Diagn Microbiol Infect Dis, 77, pp.169~173 (2013)
45. Swaminathan M, "Prevalence and risk factors for acquisition of carbapenem-resistant Enterobacteriaceae in the setting of endemicity", Infect Control Hosp Epidemiol, 34, pp.809~817 (2013)
46. Leavitt A, "Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital", Antimicrob Agents Chemother, 51, pp.3026~3029 (2007)
47. Wei ZQ, "Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China", Antimicrob Agents Chemother, 51, pp.763~765 (2007)
48. McConville TH, "Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study", PLoS One, 12, pp.e0186195~ (2017)
49. Lin MY, "Predicting carbapenem-resistant Enterobacteriaceae carriage at the time of admission using a statewide hospital discharge database", Open Forum Infect Dis, 6, pp.ofz483~ (2019)
50. Prabaker K, "Transfer from high-acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae : a multihospital study", Infect Control Hosp Epidemiol, 33, pp.1193~1199 (2012)
51. Reuben J, "Healthcare antibiotic resistance prevalence: DC (HARP-DC). A regional prevalence assessment of carbapenem-resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia", Infect Control Hosp Epidemiol, 38, pp.921~929 (2017)
52. Korea Disease Control and Prevention Agency, "CRE infection continue to increase, strengthen infection control" (2020), Korea Disease Control and Prevention Agency
53. Schwaber MJ, "An ongoing national intervention to contain the spread of carbapenem-resistant Enterobacteriaceae", Clin Infect Dis, 58, pp.697~703 (2014)
54. Dickstein Y, "Carbapenem-resistant Enterobacteriaceae colonization and infection in critically ill patients : a retrospective matched cohort comparison with non-carriers", J Hosp Infect, 94, pp.54~59 (2016)
55. Martín-Loeches I, "Risks for multidrug-resistant pathogens in the ICU", Curr Opin Crit Care, 20, pp.516~524 (2014)
56. Tamma PD, "Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae bacteremia", Clin Infect Dis, 64, pp.257~264 (2017)
57. Satlin MJ, "Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United Stat", Antimicrob Agents Chemother, 61, pp.e02349~e02316 (2017)
58. Martin A, "Association between carbapenem resistance and mortality among adult, hospitalized patients with serious infections due to Enterobacteriaceae:results of a systematic literature review and meta-analysis", Open Forum Infect Dis, 5, pp.ofy150~ (2018)
59. (2015)[URL]
60. Korea Disease Control and Prevention Agency, "Guideline for control of healthcare-associated infection, 2021", Korea Disease Control and Prevention Agency, ~ (2021)
61. Boyce JM, "Guideline for hand hygiene in health-care settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC", SHEA, IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America, pp.Association for Professionals in Infection Control, Infectious Diseases Society of America[DOI]
62. Kim YK, "Clinical factors predicting persistent carriage of Klebsiella pneumoniae carbapenemase-producing carbapenem-resistant Enterobacteriaceae among patients with known carriage", J Hosp Infect, 99, pp.405~412 (2018)
63. Papadimitriou-Olivgeris M, "Risk factors for KPCproducing Klebsiella pneumoniae enteric colonization upon ICU admission", J Antimicrob Chemother, 67, pp.2976~2981 (2012)
64. Kizny Gordon AE, "The hospital water environment as a reservoir for carbapenem-resistant organisms causing hospitalacquired infections : a systematic review of the literature", Clin Infect Dis, 64, pp.1435~1444 (2017)
65. Smolders D, "Acetic acid as a decontamination method for ICU sink drains colonized by carbapenemase-producing Enterobacteriaceae and its effect on CPE infections", J Hosp Infect, 102, pp.82~88 (2019)
66. Kim MN, "Multidrug-resistant organisms and healthcare-associated infections", Hanyang Med Rev, 31, pp.141~152 (2011)
67. 최영화, "우리나라 의료 관련 감염 감시체계", 대한의사협회지, 61(1), pp.21~25 (2018), 대한의사협회[DOI]
68. 곽이경, "전국의료관련감염감시체계 중환자실 부문 결과 보고: 2016년 7월부터 2017년 6월", 의료관련감염관리, 23(2), pp.25~38 (2018), 대한의료관련감염관리학회
69. Kochar S, "Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae", Infect Control Hosp Epidemiol, 30, pp.447~452 (2009)
70. Ho KW, "Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: is it cost-effective in a nonendemic region?", Am J Infect Control, 44, pp.394~399 (2016)
71. Richter SS, "Screening for carbapenem-resistant Enterobacteriaceae: who, when, and how?", Virulence, 8, pp.417~426 (2017)
72. Arena F, "Diversity of the epidemiology of carbapenemase-producing Enterobacteriaceae in long-term acute care rehabilitation settings from an area of hyperendemicity, and evaluation of an intervention bundle", J Hosp Infect, 100, pp.29~34 (2018)
73. Landman D, "Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures", J Clin Microbiol, 43, pp.5639~5641 (2005)
74. Blackburn J, "Carbapenem disks on MacConkey agar in screening methods for detection of carbapenem-resistant Gram-negative rods in stools", J Clin Microbiol, 51, pp.331~333 (2013)

관련 논문AI추천